Home
Placeholder for missing image of Xiongyu Wu

Xiongyu Wu

Principal Research Engineer

Förste forskningsingenjör

Publications

2025

Steven R. Baginski, Karin Lindbom, Bryan Valencia Crespo, Ghidaa Bessa, Tobias Rautio, Xiongyu Wu, Johan Dahlén, Lorna A. Nisbet, Craig McKenzie, Henrik Green (2025) Structure-metabolism relationships of 4-pentenyl synthetic cannabinoid receptor agonists using in vitro human hepatocyte incubations and high-resolution mass spectrometry Archives of Toxicology (Article in journal) Continue to DOI
Henrik Green, Craig McKenzie, Elias Hamra, Tobias Rautio, Xiongyu Wu, Emma Juneskog, Rebecka Sandblom, Manuela Monti, Mattias Persson, Caitlyn Norman (2025) In vitro CB1 receptor activity of halogenated indazole synthetic cannabinoid receptor agonists Archives of Toxicology (Article in journal) Continue to DOI
Tobias Rautio, Robin Obrist, Lucas Krebs, Therése Klingstedt, Johan Dahlén, Xiongyu Wu, Henrik Green (2025) In vitro metabolism study of ADB-P-5Br-INACA and ADB-4en-P-5Br-INACA using human hepatocytes, liver microsomes, and in-house synthesized references Drug Testing and Analysis, Vol. 17, p. 701-712 (Article in journal) Continue to DOI
Karin Lindbom, Caitlyn Norman, Steven Baginski, Lucas Krebs, Darta Stalberga, Tobias Rautio, Xiongyu Wu, Robert Kronstrand, Henrik Green (2025) Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples Drug Testing and Analysis, Vol. 17, p. 372-386 (Article in journal) Continue to DOI

2024

Xiongyu Wu, Hamid Shirani, Ruben Vidal, Bernardino Ghetti, Martin Ingelsson, Therése Klingstedt, Peter Nilsson (2024) Distinct Chemical Determinants are Essential for Achieving Ligands for Superior Optical Detection of Specific Amyloid-ß Deposits in Alzheimer's Disease ChemistryOpen, Vol. 13, Article e202400186 (Article in journal) Continue to DOI

News

Nina Ottosson in the lab.

A drug from resin to combat epileptic seizures

New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy. A study published in the journal Epilepsia shows that several of the molecules have antiseizure effects.
Female scientist lecturing.

New method to dampen nerve signals

Researchers at LiU have discovered a previously unknown molecular binding site that can influence electrical impulses in nerves. The discovery opens the possibility of designing new types of drugs against conditions such as epilepsy.

Tags